Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy

Acta Oncologica

Volumn 38, Issue 1, 1999, Pages 111-116

  Khafaga, Yasser M ^a   Jamshed, Arif ^a   Allam, Ayman A K ^a   Mourad, Walid A ^a   Al Eisa, Abdullah ^a   Ezzat, Adnan ^a   Gray, Alan J ^a   Schultz, Henrik ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; DEXAMETHASONE; MIDAZOLAM; MORPHINE; PENICILLIN G; PHENYTOIN; SULFONAMIDE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHEMOTHERAPY; CLINICAL FEATURE; DRUG EFFICACY; ERYTHEMA MULTIFORME; FEMALE; GLIOBLASTOMA; HUMAN; MALE; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; RADIATION INJURIES; STEVENS-JOHNSON SYNDROME;

EID: 0033056918     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431898     Document Type: Article

References (20)

1. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131: 539-43.
2. Bastuji-Garin S, Rzany B, Stern RS. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-6.
3. Cote B, Wechsler J, Bastuji-Garin S, Assier H, Revuz J, Roujeau JC. Clinicopathologic correlation in erythema multiforme and Stevens Johnson syndrome. Arch Dermatol 1995; 131: 1268-72.
4. Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrosis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997; 24: 726-9.
5. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet M-L, Girre JP. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990; 126: 37-42.
6. Chan HL, Stern RS, Kenneth AA, et al. The incidence of erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 1990; 126: 43.
7. Burkhart CG, Smith MR. Erythema multiforme induced by radiotherapy. J Am Acad Dermatol 1980; 3: 94.
8. Chalmers D. Fatal case of erythema multiforme following deep x-ray therapy. Br J Dermatol 1959; 71: 256-60.
9. Borg MF, Probert JC, Zwi LJ. Is phenytoin contraindicated in patients receiving cranial irradiation? Australas Radiol 1995; 39: 42-6.
10. Nawalkha PL, Mathur NK, Malhotra YK. Severe erythema multiforme (Stevens Johnson syndrome) following telecobalt therapy. Br J Radiol 1972; 45: 768.
11. Dellatre JY, Safai B, Posner JB. Erythema multiforme and Stevens Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988; 38: 194-8.
12. Maiche A, Teerenhovi L. Stevens Johnson syndrome in patients receiving radiotherapy. Lancet 1985; 45: 8445.
13. Fitzpatrick TB, Bernhard JD. Skin lesions of general medical significance. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al. Harrison's principles of internal medicine 11th edition. New York: McGrawHill Book Co, 1987: 232-40.
14. Millikan LE. Erythema multiforme. In: Moschella S, Hurley HJ, eds. Dermatology. New York: WB Saunders, 1985: 437-83.
15. Marvin JA, Heimbach DM, Engrav LH. Improved treatment of Stevens Johnson syndrome. Arch Surg 1984; 119: 601-5.
16. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Metabolic predisposition to cutaneous adverse drug reactions, role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995; 131: 544-51.
17. Halvey S, Grunwald MH, Sandbank M, Buimovice B, Joshua H, Livni E. Macrophage migration inhibition factor (MIF) in drug eruption. Arch Dermatol 1990; 126: 48-51.
18. Guibal F, Bastuji-Garin S, Chosidow O, Saiag P, Revuz J, Roujeau JC. Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995; 131: 669-72.
19. Roujeau JC, Huynth TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171-3.
20. Stitt VJ. Stevens-Johnson syndrome: a review of the literature. J Natl Med Assoc 1988; 80: 104-8.